In focus
LIPSIA-STRATEGY Trial Backs Angiography-Derived CAAS vFFR as Wire-Free Alternative for Coronary Revascularization
The LIPSIA-STRATEGY trial found CAAS vFFR-guided revascularization non-inferior to pressure wire-based FFR in 1,053 patients with intermediate coronary stenoses, adding randomized evidence that could reshape physiology-guided PCI workflows.
Read the story